Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 24, 2013 - Issue 1
Submit an article Journal homepage
336
Views
24
CrossRef citations to date
0
Altmetric
Psoriasis

How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center

Faranak KamangarDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA; School of Medicine, University of California, Davis, Sacramento, California, USA
,
Leah IsipDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA
,
Tina BhutaniDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA
,
Madison DennisDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA
,
Misha M HellerDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA; Keck School of Medicine, University of Southern California, Los Angeles, California, USA
,
Eric S LeeDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA; College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
,
Hong Nie Ernest Gallo Clinic and Research Center, Emeryville, California, USA
&
Wilson LiaoDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USACorrespondence[email protected]
 show all
Pages 13-24 | Received 14 Jun 2011, Accepted 02 Oct 2011, Published online: 10 Nov 2011

References

  • Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826–850.
  • Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav. 2000;70:567–571.
  • Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National PSORIASIS Foundation patient-membership survey. Arch Dermatol. 2001;137:280–284.
  • Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139:846–850.
  • Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999; Sep;41(3 Pt 1):401–407; PMID: 10459113.
  • Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851–864.
  • Castelo-Soccio L, Van Voorhees AS. Long-term efficacy of biologics in dermatology. Dermatol Ther. 2009;22:22–33.
  • Menter A. The effect of psoriasis on patients' quality of life and improvements associated with alefacept therapy. J Cutan Med Surg. 2004;8:20–25.
  • Katugampola RP, Lewis VJ, Finlay AY. The dermatology life quality index: assessing the efficacy of biological therapies for psoriasis. Br J Dermatol. 2007;156:945–950.
  • Finlay AY, Ortonne JP. Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy. J Cutan Med Surg. 2004;8:310–320.
  • Jones-Caballero M, Unaeze J, Penas PF, Stern RS. Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective. Arch Dermatol. 2007;143:846–850.
  • zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140:408–414.
  • Driessen RJ, Bisschops LA, Adang EM, Evers AW, Van De Kerkhof PC, De Jong EM. The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics. Br J Dermatol. 2010;162:1324–1329.
  • Sizto S, Bansback N, Feldman SR, Willian MK, Anis AH. Economic evaluation of systemic therapies for moderate to severe psoriasis. Br J Dermatol. 2009;160:1264–1272.
  • Stein KR, Pearce DJ, Feldman SR. The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care. Semin Cutan Med Surg. 2005;24:52–57.
  • Mahler R, Jackson C, Ijacu H. The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey. J Cutan Med Surg. 2009;13:283–293.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.